Avalo Therapeutics Inc. Gains 70.03%

Wed, Dec 13, 2023 at 07:30 PM

Avalo Therapeutics Inc. (AVTX:NASDAQ) shot up at $0.06, a gain of 70%. On Wed, Dec 13, 2023, AVTX:NASDAQ hit a New 2-Week Intraday High of $0.08. The stock got featured on our News Catalysts scanner on Thu, Dec 07, 2023 at 10:03 AM in the 'SPLIT' category. From Thu, Nov 30, 2023, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Wed, Dec 13, 2023 at $0.08 with a volume of 270M+.

About Avalo Therapeutics Inc. (AVTX:NASDAQ)

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in...

Top 10 Gainers:

Kubient Inc. (KBNT:NASDAQ), 280.77%
C4 Therapeutics Inc. (CCCC:NASDAQ), 135.47%
Shattuck Labs Inc. (STTK:NASDAQ), 130.33%
Signature Bank (SBNY:NASDAQ), 96.72%
Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
Avalo Therapeutics Inc. (AVTX:NASDAQ), 70.03%
NextPlay Technologies Inc. (NXTP:NASDAQ), 68.87%
LQR House Inc. (LQR:NASDAQ), 65.89%
View Inc. (VIEW:NASDAQ), 65.15%
ADC Therapeutics SA (ADCT:NYSE), 63.11%